Approach to intrapartum fever during the COVID-19 pandemic: A New York City Hospital experience. Academic Article uri icon

Overview

abstract

  • The yield of repeat severe acute respiratory syndrome coronovirus 2 (SARS-CoV-2) testing for intrapartum fever in patients admitted to labor and delivery negative for SARS-CoV-2 on admission testing is unknown. From October 2020 to June 2022, we performed a retrospective study of 151/3,168 (4.8%) patients who had repeat testing for intrapartum fever. One (0.7%) patient was SARS-CoV-2-positive suggesting repeat SARS-CoV-2 testing for intrapartum fever is generally not warranted nor is separating birthing dyads while awaiting test results.

publication date

  • April 5, 2024

Research

keywords

  • COVID-19
  • Fever
  • Pregnancy Complications, Infectious
  • SARS-CoV-2

Identity

Scopus Document Identifier

  • 85191596956

Digital Object Identifier (DOI)

  • 10.1016/j.ajic.2024.04.002

PubMed ID

  • 38583775

Additional Document Info

volume

  • 52

issue

  • 7